First Trust Advisors’s Cabaletta Bio CABA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-35,952
Closed -$309K 2528
2021
Q2
$309K Sell
35,952
-243
-0.7% -$2.39K ﹤0.01% 2365
2021
Q1
$402K Buy
36,195
+2,905
+9% +$35.5K ﹤0.01% 2273
2020
Q4
$415K Sell
33,290
-1,474
-4% -$19.1K ﹤0.01% 2157
2020
Q3
$377K Buy
+34,764
New +$400K ﹤0.01% 2111

Other funds holding CABA

First Trust Advisors's CABA Position: Q3 2021 in Review

First Trust Advisors sold out of Cabaletta Bio (CABA) in Q3 2021, closing a stake of 35,952 shares — an estimated $309K sold.

First Trust Advisors first reported a position in CABA in Q3 2020 and held it in 4 quarters. The position peaked at $415K in Q4 2020. 61 funds tracked by Wall St. Rank hold CABA as of Q3 2021.

  • First Trust Advisors reported no remaining Cabaletta Bio position as of Q3 2021 after selling out during the quarter.
  • First Trust Advisors sold 35,952 Cabaletta Bio shares in Q3 2021, an estimated $309K.
  • First Trust Advisors first reported a position in Cabaletta Bio in Q3 2020 and held it in 4 quarters.
  • First Trust Advisors's Cabaletta Bio position peaked at $415K in Q4 2020.
  • 61 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2021.

Based on First Trust Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.